Fig. 3. Arctigenin increases the Bax/Bcl-2 ratio in SK-BR-3 cells. SK-BR-3 cells were treated with an indicated dose of arctigenin for 24 hours. The cell lysates were subjected to Western blot. (A) The level of Bax and Bcl-2. (B) Each band intensity from the data was normalized to GAPDH and the Bax/Bcl-2 ratio was calculated. Data were presented as mean ± standard error of the mean of three independent experiments and analyzed by Student’s t-test. ***P < 0.001 vs. non-treated control in SK-BR-3 cells.
© 2024 Biomed Sci Letters